Sotera Health Company
SHC
$11.50
$0.373.32%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 4.88% | 13.11% | 12.50% | 9.05% | 4.54% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 4.88% | 13.11% | 12.50% | 9.05% | 4.54% |
Cost of Revenue | 5.51% | 11.20% | 10.03% | 8.09% | 5.70% |
Gross Profit | 4.36% | 14.70% | 14.59% | 9.85% | 3.62% |
SG&A Expenses | 9.86% | 12.14% | 9.89% | 9.88% | 12.16% |
Depreciation & Amortization | -2.76% | -2.11% | -1.62% | -0.03% | 1.36% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.90% | 10.23% | 8.92% | 7.79% | 6.88% |
Operating Income | 2.61% | 19.90% | 21.05% | 11.89% | -0.28% |
Income Before Tax | 7.40% | 139.80% | 131.12% | 139.45% | 143.61% |
Income Tax Expenses | 27.13% | 305.08% | 284.28% | 362.79% | 672.80% |
Earnings from Continuing Operations | -13.58% | 123.05% | 114.95% | 120.99% | 122.00% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -13.58% | 123.05% | 114.95% | 120.99% | 122.00% |
EBIT | 2.61% | 19.90% | 21.05% | 11.89% | -0.28% |
EBITDA | 2.97% | 15.41% | 15.52% | 10.14% | 2.46% |
EPS Basic | -13.56% | 122.89% | 114.81% | 120.81% | 121.79% |
Normalized Basic EPS | -9.32% | 18.37% | 5.65% | -9.62% | -24.90% |
EPS Diluted | -13.13% | 122.45% | 114.24% | 120.02% | 121.18% |
Normalized Diluted EPS | -9.54% | 17.86% | 5.41% | -10.05% | -25.30% |
Average Basic Shares Outstanding | 0.63% | 0.54% | 0.45% | 0.36% | 0.33% |
Average Diluted Shares Outstanding | 0.83% | 0.87% | 0.56% | 0.70% | 0.88% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |